학술논문

US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era
Document Type
Article
Source
In: Cytotherapy. (Cytotherapy, April 2024, 26(4):393-403)
Subject
Language
English
ISSN
14772566
14653249